Hepatic Damage by Natural Remedies

Raul J. Andrade; Inmaculada Medina-Caliz; Andres Gonzalez-Jimenez; Miren Garcia-Cortes; M. Isabel Lucena

doi:10.1055/s-0038-1623518

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2018; 38(01): 021-040
DOI: 10.1055/s-0038-1623518

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hepatic Damage by Natural Remedies

Raul J. Andrade

¹Unidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

²Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain

,

Inmaculada Medina-Caliz

³Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

,

Andres Gonzalez-Jimenez

³Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

,

Miren Garcia-Cortes

¹Unidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

²Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain

,

M. Isabel Lucena

²Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain

³Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain

⁴Unidad Investigación Clínica y Ensayos Clínicos (UICEC)-IBIMA, Plataforma Spanish Clinical Research Network, Spain

› Author Affiliations

Abstract

The rising burden of herbal and dietary supplement hepatotoxicity (HILI) is a growing concern in Western countries. The estimated incidence of HILI in well-designed prospective studies ranges from less than 1 to 3 individuals per 100,000 inhabitants/year. Herbal hepatotoxicity has a particular signature encompassing female predominance, hepatocellular type of damage with markedly elevated transaminases on presentation, more common unintentional rechallenge, and a greater risk of death/liver transplantation. Herbal hepatotoxicity recognition is particularly challenging for hepatologists because of the often hidden herbal consumption, difficulties in identifying the causative herbal component, and the possibility of contamination, adulteration, and misidentification, which preclude a proper adjudication and lead to inaccurate reporting of cases in scientific journals. Collaborative efforts to retrieve detailed phenotypic data and biological samples of patients with HILI would facilitate genomic and other molecular approaches for a better understanding of host risk factors and, hopefully, for biomarker identification.

Keywords

hepatotoxicity - herbal-induced liver injury - diagnosis

Full Text

References

References
1 Huxtable RJ. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 1992; 117 (02) 165-166
2 Soares J. The Nagoya Protocol and natural product-based research. ACS Chem Biol 2011; 6 (04) 289
3 Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. Semin Liver Dis 2014; 34 (02) 172-193
4 Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177
5 Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med (Lond) 2013; 13 (02) 126-131
6 Garcia-Alvarez A, Egan B, de Klein S. , et al. Usage of plant food supplements across six European countries: findings from the PlantLIBRA consumer survey. PLoS One 2014; 9 (03) e92265
7 Kennedy ET, Luo H, Houser RF. Dietary supplement use pattern of U.S. adult population in the 2007-2008 National Health and Nutrition Examination Survey (NHANES). Ecol Food Nutr 2013; 52 (01) 76-84
8 Dickinson A, Blatman J, El-Dash N, Franco JC. Consumer usage and reasons for using dietary supplements: report of a series of surveys. J Am Coll Nutr 2014; 33 (02) 176-182
9 Eisenberg DM, Davis RB, Ettner SL. , et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280 (18) 1569-1575
10 Seeff LB. Are herbals as safe as their advocates believe?. J Hepatol 2009; 50 (01) 13-16
11 Goldstein LH, Elias M, Ron-Avraham G. , et al. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br J Clin Pharmacol 2007; 64 (03) 373-380
12 Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013; 75 (03) 603-618
13 Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E. Adverse events associated with interactions with dietary and herbal supplements among inpatients. Br J Clin Pharmacol 2017; 83 (04) 836-845
14 Wu CH, Wang CC, Kennedy J. Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther 2011; 33 (11) 1749-1758
15 Morris CA, Avorn J. Internet marketing of herbal products. JAMA 2003; 290 (11) 1505-1509
16 Griffiths P, Gossop M, Wickenden S, Dunworth J, Harris K, Lloyd C. A transcultural pattern of drug use: qat (khat) in the UK. Br J Psychiatry 1997; 170: 281-284
17 Rivera JO, Loya AM, Ceballos R. Use of herbal medicines and implications for conventional drug therapy medical sciences. Altern Integr Med 2013; 2: 130
18 Global Herbal Supplements and Remedies Market to Reach US$107 Billion by 2017. According to New Report by Global Industry Analysts, Inc. http://www.prweb.com/releases/herbal_supplements/herbal_remedies/prweb9260421.htm . Accessed September 10, 2017
19 Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Rep 2009; 18 (18) 1-14
20 Austin SB, Yu K, Liu SH, Dong F, Tefft N. Household expenditures on dietary supplements sold for weight loss, muscle building, and sexual function: Disproportionate burden by gender and income. Prev Med Rep 2017; 6: 236-241
21 Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. https://ods.od.nih.gov/About/DSHEA_Wording.aspx . Accessed September 11, 2017
22 Avigan MI, Mozersky RP, Seeff LB. Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. Int J Mol Sci 2016; 17 (03) 331
23 Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Off J Eur Union 2004; L136: 85-90
24 European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000264.jsp . Accessed September 11, 2017
25 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. Off J Eur Union 2002; L183: 51-53
26 World Health Organization. WHO Traditional Medicine Strategy: 2014–2023. Available at http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/ . Accessed February 10, 2017
27 Seeff LB, Bonkovsky HL, Navarro VJ, Wang G. Herbal products and the liver: a review of adverse effects and mechanisms. Gastroenterology 2015; 148 (03) 517-532.e3
28 Brown AC. Liver toxicity related to herbs and dietary supplements: online table of case reports. Part 2 of 5 series. Food Chem Toxicol 2017; 107 (Pt A): 472-501
29 Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology 2017; 65 (01) 363-373
30 Vega M, Verma M, Beswick D. , et al; Drug Induced Liver Injury Network (DILIN). The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the State of Delaware. Drug Saf 2017; 40 (09) 783-787
31 Suk KT, Kim DJ, Kim CH. , et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012; 107 (09) 1380-1387
32 Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013; 144 (07) 1419-1425 , 1425.e1–1425.e3, quiz e19–e20
33 Wai CT, Tan BH, Chan CL. , et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27 (04) 465-474
34 Zhu Y, Niu M, Chen J. , et al; Specialized Committee for Drug-Induced Liver Diseases, Division of Drug-Induced Diseases, Chinese Pharmacological Society. Hepatobiliary and pancreatic: comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 2016; 31 (08) 1476-1482
35 Navarro VJ, Barnhart H, Bonkovsky HL. , et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014; 60 (04) 1399-1408
36 García-Cortés M, Borraz Y, Lucena MI. , et al. Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry [in Spanish]. Rev Esp Enferm Dig 2008; 100 (11) 688-695
37 Robles-Diaz M, Gonzalez-Jimenez A, Medina-Caliz I. , et al; Spanish DILI Registry; SLatinDILI Network. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther 2015; 41 (01) 116-125
38 Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A. , et al. Herbal and dietary supplements-induced liver injury in the Spanish DILI Registry. Clin Gastroenterol Hepatol 2018; DOI: 10.1016/j.cgh.2017.12.051. [Epub ahead of print]
39 Slim M, Sanabria J, Robles-Diaz M. , et al. Spanish Drug-Induced Liver Injury Registry: an update of 20-years prospective collection of idiosyncratic hepatotoxicity cases. [abstract] Hepatology 2016; 64: 66A
40 Douros A, Bronder E, Andersohn F. , et al. Herb-induced liver injury in the Berlin Case-Control Surveillance Study. Int J Mol Sci 2016; 17 (01) 114
41 Bessone F, Nelia H, Sanchez-Ciceron A. , et al. A comparative analysis of the Spanish and Latin-American prospective drug-induced liver injury (DILI) networks. [abstract] Hepatology 2015; 62: 504A
42 Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol 2010; 105 (11) 2396-2404
43 Dağ MS, Aydınlı M, Oztürk ZA. , et al. Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol 2014; 25 (01) 41-45
44 Zhou Y, Yang L, Liao Z, He X, Zhou Y, Guo H. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol 2013; 25 (07) 825-829
45 Ocete Hita E, Martín García JA, Giménez Sánchez F. , et al. Hepatotoxicity due to drugs or natural products in children [in Spanish]. An Pediatr (Barc) 2013; 78 (04) 248-259
46 Reuben A, Koch DG, Lee WM. ; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52 (06) 2065-2076
47 Hillman L, Gottfried M, Whitsett M. , et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol 2016; 111 (07) 958-965
48 Goldberg DS, Forde KA, Carbonari DM. , et al. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology 2015; 148 (07) 1353-61.e3
49 Zhao P, Wang C, Liu W, Wang F. Acute liver failure associated with traditional Chinese medicine: report of 30 cases from seven tertiary hospitals in China*. Crit Care Med 2014; 42 (04) e296-e299
50 Kullak-Ublick GA, Andrade RJ, Merz M. , et al. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017; 66 (06) 1154-1164
51 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case characterization, clinical features and risk factors in drug-induced liver injury. Int J Mol Sci 2016; 17 (05) E714
52 Manso G, López-Rivas L, Salgueiro ME. , et al. Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury. Pharmacoepidemiol Drug Saf 2011; 20 (10) 1080-1087
53 National Institutes of Health. Dietary Supplement Label Database (DSLD). https://www.dsld.nlm.nih.gov/dsld/ . Accessed August 1, 2017
54 Fernández-Castañer A, García-Cortés M, Lucena MI. , et al. An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event [in Spanish]. Rev Esp Enferm Dig 2008; 100 (05) 278-284
55 Stickel F, Shouval D. Hepatotoxicity of herbal and dietary supplements: an update. Arch Toxicol 2015; 89 (06) 851-865
56 de Boer YS, Sherker AH. Herbal and dietary supplement-induced liver injury. Clin Liver Dis 2017; 21 (01) 135-149
57 LiverTox: Herbals and Dietary Supplements. https://livertox.nih.gov/Herbals_and_Dietary_Supplements.htm . Accessed August 1, 2017
58 García-Cortés M, Robles-Díaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci 2016; 17 (04) 537
59 Robles-Diaz M, Lucena MI, Kaplowitz N. , et al; Spanish DILI Registry; SLatinDILI Network; Safer and Faster Evidence-based Translation Consortium. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology 2014; 147 (01) 109-118.e5
60 Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013; 75 (03) 630-636
61 Davern TJ, Chalasani N, Fontana RJ. , et al; Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141 (05) 1665-72.e1 , 9
62 Sanjuan-Jimenez R, Robles-Díaz M, Sanabria-Cabrera J. , et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury. [abstract] Hepatology 2017; 66: 1149-1185
63 Hoofnagle JH, Nelson KE, Purcell RH, Hepatitis E. Hepatitis E. N Engl J Med 2012; 367 (13) 1237-1244
64 Kleiner DE. Histopathological challenges in suspected drug-induced liver injury. Liver Int 2017
65 Suzuki A, Brunt EM, Kleiner DE. , et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011; 54 (03) 931-939
66 Foureau DM, Walling TL, Maddukuri V. , et al. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis. Clin Exp Immunol 2015; 180 (01) 40-51
67 Bonkovsky HL, Kleiner DE, Gu J. , et al; U.S. Drug Induced Liver Injury Network Investigators. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology 2017; 65 (04) 1267-1277
68 Nathwani RA, Kumar SR, Reynolds TB, Kaplowitz N. Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis. Am J Gastroenterol 2005; 100 (02) 295-298
69 Gudnason HO, Björnsson HK, Gardarsdottir M. , et al. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Dig Liver Dis 2015; 47 (06) 502-507
70 Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46 (11) 1323-1330
71 García-Cortés M, Stephens C, Lucena MI, Fernández-Castañer A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 2011; 55 (03) 683-691
72 Cohen PA. Hazards of hindsight--monitoring the safety of nutritional supplements. N Engl J Med 2014; 370 (14) 1277-1280
73 Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci 2015; 17 (01) 14
74 García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ. ; Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham). Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008; 27 (09) 780-789
75 Lin G, Wang JY, Li N. , et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 2011; 54 (04) 666-673
76 Larrey D, Vial T, Pauwels A. , et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117 (02) 129-132
77 Larrey D, Faure S. Herbal medicine hepatotoxicity: a new step with development of specific biomarkers. J Hepatol 2011; 54 (04) 599-601
78 De Berardinis V, Moulis C, Maurice M. , et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000; 58 (03) 542-551
79 Navarro VJ, Bonkovsky HL, Hwang S-I, Vega M, Barnhart H, Serrano J. Catechins in dietary supplements and hepatotoxicity. Dig Dis Sci 2013; 58 (09) 2682-2690
80 Matthews HB, Lucier GW, Fisher KD. Medicinal herbs in the United States: research needs. Environ Health Perspect 1999; 107 (10) 773-778
81 de Mel Y, Perera S, Ratnaweera PB, Jayasinghe CD. Review article novel insights of toxicological evaluation of herbal medicine. Human Based Toxicol Assays 2017; 3: 41-49
82 Stoeckle MY, Gamble CC, Kirpekar R, Young G, Ahmed S, Little DP. Commercial teas highlight plant DNA barcode identification successes and obstacles. Sci Rep 2011; 1: 42
83 Agarwal VK, McHutchison JG, Hoofnagle JH. ; Drug-Induced Liver Injury Network. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol 2010; 8 (05) 463-470
84 Yang HN, Kim DJ, Kim YM. , et al. Aloe-induced toxic hepatitis. J Korean Med Sci 2010; 25 (03) 492-495
85 Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R. Acute hepatitis induced by an Aloe vera preparation: a case report. World J Gastroenterol 2005; 11 (02) 303-304
86 Teschke R, Bahre R. Severe hepatotoxicity by Indian ayurvedic herbal products: a structured causality assessment. Ann Hepatol 2009; 8 (03) 258-266
87 Fleig W, Morgan M, Hölzer M. The ayurvedic drug LIV.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial. [abstract] J Hepatol 1997; 26: 127
88 Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012; 32 (10) 1543-1556
89 Chou SL, Chou MY, Kao WF. , et al. Bajiaolian poisoning-a poisoning with high misdiagnostic rate. Am J Emerg Med 2010; 28 (01) 85-89
90 Teschke R. Traditional Chinese Medicine induced liver injury. J Clin Transl Hepatol 2014; 2 (02) 80-94
91 Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005; 43 (05) 901-910
92 Kaplowitz N, DeLeve L. Drug-Induced Liver Disease. 3rd ed. Boston: Academic Press; 2013: 632-647
93 Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23 (03) 366-373
94 Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 2004; 11 (05) 575-577
95 European Medicines Agency. Assessment report on Cimicifuga racemosa (L.) Nutt., rhizoma. http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2011/05/WC500106358.pdf . Accessed June 20, 2017
96 Agencia Española de Medicamentos y Productos Sanitarios. Notas informativas 2006. Extracto de la raíz de Cimifuga Racemosa y lesiones hepáticas. https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2006/NI_2006-06_cimicifuga.htm . Accessed June 20, 2017
97 Cheung WI, Tse ML, Ngan T. , et al. Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine. Clin Toxicol (Phila) 2009; 47 (07) 683-685
98 Piscaglia F, Leoni S, Venturi A, Graziella F, Donati G, Bolondi L. Caution in the use of boldo in herbal laxatives: a case of hepatotoxicity. Scand J Gastroenterol 2005; 40 (02) 236-239
99 European Medicines Agency. European Union herbal monograph on Peumus boldus Molina, folium. http://www.fitoterapia.net/archivos/201701/wc500219581.pdf . Accessed January 7, 2017
100 Uc A, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J 2000; 93 (06) 596-598
101 Jimenez JF, Brown AL, Arnold WC, Byrne WJ. Chronic camphor ingestion mimicking Reye's syndrome. Gastroenterology 1983; 84 (02) 394-398
102 Nadir A, Reddy D, Van Thiel DH. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000; 95 (12) 3634-3637
103 Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm Dig 2005; 97 (02) 115-124
104 Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157 (08) 913-919
105 Adachi M, Saito H, Kobayashi H. , et al. Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med 2003; 139 (06) 488-492
106 Lin T-J, Su C-C, Lan C-K, Jiang DD, Tsai J-L, Tsai M-S. Acute poisonings with Breynia officinalis--an outbreak of hepatotoxicity. J Toxicol Clin Toxicol 2003; 41 (05) 591-594
107 Lin TJ, Tsai MS, Chiou NM, Deng JF, Chiu NY. Hepatotoxicity caused by Breynia officinalis. Vet Hum Toxicol 2002; 44 (02) 87-88
108 Weston CF, Cooper BT, Davies JD, Levine DF. Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J (Clin Res Ed) 1987; 295 (6591): 183
109 Bruguera M, Herrera S, Lázaro E, Madurga M, Navarro M, de Abajo FJ. Acute hepatitis associated with Colpachi intake. Apropros of 5 cases [in Spanish]. Gastroenterol Hepatol 2007; 30 (02) 66-68
110 Abraham K, Wöhrlin F, Lindtner O, Heinemeyer G, Lampen A. Toxicology and risk assessment of coumarin: focus on human data. Mol Nutr Food Res 2010; 54 (02) 228-239
111 European Medicines Agency. Assessment report for the development of community monographs and for inclusion of herbal substance(s), preparation(s) or combinations thereof in the list. Melilotus officinalis (L.) Lam., herba. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2010/01/WC500059266.pdf . Accessed August 29, 2017
112 Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995; 40 (08) 1845-1848
113 Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92 (04) 703-704
114 Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007; 11 (03) 577-596 , vii
115 Daniele C, Dahamna S, Firuzi O, Sekfali N, Saso L, Mazzanti G. Atractylis gummifera L. poisoning: an ethnopharmacological review. J Ethnopharmacol 2005; 97 (02) 175-181
116 Bouziri A, Hamdi A, Menif K, Ben Jaballah N. Hepatorenal injury induced by cutaneous application of Atractylis gummifera L. Clin Toxicol (Phila) 2010; 48 (07) 752-754
117 Andrade RJ, Lucena MI, García-Cortés M. Hepatotoxicity due to herbal infusion [in Spanish]. Gastroenterol Hepatol 2002; 25 (05) 327-332
118 Jacobsson I, Jönsson AK, Gerdén B, Hägg S. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden. Pharmacoepidemiol Drug Saf 2009; 18 (11) 1039-1047
119 Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004; 90 (02) 408-413
120 Kocaman O, Hulagu S, Senturk O. Echinacea-induced severe acute hepatitis with features of cholestatic autoimmune hepatitis. Eur J Intern Med 2008; 19 (02) 148
121 Yuen MF, Tam S, Fung J, Wong DKH, Wong BCY, Lai CL. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 2006; 24 (08) 1179-1186
122 Shah M, Williams C, Aggarwal A, Choudhry WM. Licorice-related rhabdomyolysis: a big price for a sweet tooth. Clin Nephrol 2012; 77 (06) 491-495
123 Zheng EX, Navarro VJ. Liver injury from herbal, dietary, and weight loss supplements: a review. J Clin Transl Hepatol 2015; 3 (02) 93-98
124 Corey R, Werner KT, Singer A. , et al. Acute liver failure associated with Garcinia cambogia use. Ann Hepatol 2016; 15 (01) 123-126
125 Lekehal M, Pessayre D, Lereau JM, Moulis C, Fouraste I, Fau D. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996; 24 (01) 212-218
126 Loeper J, Descatoire V, Letteron P. , et al. Hepatotoxicity of germander in mice. Gastroenterology 1994; 106 (02) 464-472
127 Fau D, Lekehal M, Farrell G. , et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997; 113 (04) 1334-1346
128 Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 1999; 117 (05) 1234-1237
129 Gloro R, Hourmand-Ollivier I, Mosquet B. , et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005; 17 (10) 1135-1137
130 Sarma DN, Barrett ML, Chavez ML. , et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 2008; 31 (06) 469-484
131 Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 2010; 48 (01) 409-416
132 Agencia Española de Medicamentos y Productos Sanitarios AEMPS. Suspension de comercialización de la especialidad farmacéutica Exolise®: Extracto etanolico de camelia sinensis (te verde). Available at http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2003/NI_2003-03_exolise.htm . Accessed July 12, 2017
133 Xiong A, Yang F, Fang L. , et al. Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid. Chem Res Toxicol 2014; 27 (05) 775-786
134 DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996; 23 (03) 589-599
135 Popat A, Shear NH, Malkiewicz I, Thomson S, Neuman MG. Mechanism of Impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cells. Clin Biochem 2002; 35 (01) 57-64
136 Watson AR, Coovadia HM, Bhoola KD. The clinical syndrome of Impila (Callilepis laureola) poisoning in children. S Afr Med J 1979; 55 (08) 290-292
137 Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 2003; 18 (05) 451-471
138 Fraquelli M, Colli A, Cocciolo M, Conte D. Adult syncytial giant cell chronic hepatitis due to herbal remedy. J Hepatol 2000; 33 (03) 505-508
139 Woolf GM, Petrovic LM, Rojter SE. , et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994; 121 (10) 729-735
140 Horowitz RS, Feldhaus K, Dart RC, Stermitz FR, Beck JJ. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996; 156 (08) 899-903
141 Picciotto A, Campo N, Brizzolara R. , et al. Chronic hepatitis induced by Jin Bu Huan. J Hepatol 1998; 28 (01) 165-167
142 Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010; 30 (09) 1270-1279
143 Teschke R, Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. JAMA 2010; 304 (19) 2174-2175
144 Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with Kava, a herbal remedy for anxiety. BMJ 2001; 322 (7279): 139
145 Stickel F, Baumüller HM, Seitz K. , et al. Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepatol 2003; 39 (01) 62-67
146 Pantano F, Tittarelli R, Mannocchi G. , et al. Hepatotoxicity induced by “the 3Ks”: Kava, Kratom and Khat. Int J Mol Sci 2016; 17 (04) 580
147 Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai 2007; 90 (01) 179-181
148 Shekelle PG, Hardy ML, Morton SC. , et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003; 289 (12) 1537-1545
149 Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 2001; 96 (05) 1654-1655
150 Skoulidis F, Alexander GJM, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol 2005; 17 (05) 581-584
151 Sinniah D, Baskaran G. Margosa oil poisoning as a cause of Reye's syndrome. Lancet 1981; 1 (8218): 487-489
152 Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981; 282 (6259): 186-187
153 Stadlbauer V, Weiss S, Payer F, Stauber RE. Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni). Am J Gastroenterol 2008; 103 (09) 2406-2407
154 Atsumi T, Fujisawa S, Tonosaki K. A comparative study of the antioxidant/prooxidant activities of eugenol and isoeugenol with various concentrations and oxidation conditions. Toxicol In Vitro 2005; 19 (08) 1025-1033
155 Hartnoll G, Moore D, Douek D. Near fatal ingestion of oil of cloves. Arch Dis Child 1993; 69 (03) 392-393
156 Thomassen D, Slattery JT, Nelson SD. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione. J Pharmacol Exp Ther 1990; 253 (02) 567-572
157 Anderson IB, Mullen WH, Meeker JE. , et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996; 124 (08) 726-734
158 Sim Y, Oh H, Oh D-SS. , et al. An experimental study on providing a scientific evidence for seven-time alcohol-steaming of Rhei Rhizoma when clinically used. BMC Complement Altern Med 2015; 15: 388
159 Ueng Y-FF, Hsieh C-HH, Don M-JJ. Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole. Food Chem Toxicol 2005; 43 (05) 707-712
160 Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of prostata. Ann Intern Med 1997; 127 (02) 169-170
161 Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005; 39 (7-8): 1353-1357
162 Soyuncu S, Cete Y, Nokay AE. Portal vein thrombosis related to Cassia angustifolia. Clin Toxicol (Phila) 2008; 46 (08) 774-777
163 Panis B, Wong DR, Hooymans PM, De Smet PAGM, Rosias PPR. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005; 41 (02) 256-258
164 MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. BMJ 1989; 299 (6708): 1156-1157
165 Philibert C, Messaoui S, Gignoux M, Pinzani V, Larrey D, Hillaire-Buys D. Liver injury from phytotherapy treatment containing soy isoflavones [in French]. Therapie 2010; 65 (05) 501-503
166 De Smet PA, Van den Eertwegh AJ, Lesterhuis W, Stricker BH. Hepatotoxicity associated with herbal tablets. BMJ 1996; 313 (7049): 92
167 Soares MdoC. Would Sacaca, Croton cajucara Benth (Euphorbiaceae) be an hepatotoxic plant like Germander, Teucrium chamaedrys L. (Labiatae)?. Rev Soc Bras Med Trop 2004; 37 (Suppl. 02) 96-97
168 Comision Federal para la Protección contra Riesgos Sanitarios. Comunicado a los consumidores del producto Capslim; 2014. Available at http://cofepris.gob.mx/AZ/Documents/COMUNICADOCAPSLIM.pdf . Accessed August 29, 2017